Article Text

Download PDFPDF

Benign intracranial hypertension associated with the withdrawal of a non-ergot dopamine agonist
  1. S L Atkin,
  2. E A Masson,
  3. L D Blumhardt,
  4. M C White
  1. Department of Endocrinology, Royal Liverpool Hospital, Liverpool, UK
  2. Division of Clinical Neurology, University Hospital, Queens Medical Centre, Nottingham, UK


    The cases are reported of two patients who developed benign intracranial hypertension after the withdrawal of the novel non-ergot derived dopamine agonist CV 205 502 (quinagolide).

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.